SG Americas Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$665K Sell
5,644
-9,249
-62% -$1.29M ﹤0.01% 2015
2025
Q4
$2.44M Sell
14,893
-69
-0.5% -$10.8K ﹤0.01% 1410
2025
Q3
$2M Buy
14,962
+12,873
+616% +$1.56M 0.01% 950
2025
Q2
$260K Sell
2,089
-903
-30% -$115K ﹤0.01% 2112
2025
Q1
$381K Sell
2,992
-455
-13% -$70K ﹤0.01% 2003
2024
Q4
$496K Sell
3,447
-3,073
-47% -$441K ﹤0.01% 1356
2024
Q3
$970K Buy
6,520
+3,701
+131% +$531K ﹤0.01% 1108
2024
Q2
$355K Sell
2,819
-919
-25% -$144K ﹤0.01% 1878
2024
Q1
$687K Sell
3,738
-3,304
-47% -$629K ﹤0.01% 1293
2023
Q4
$1.27M Sell
7,042
-20,073
-74% -$3.12M 0.01% 897
2023
Q3
$4.31M Buy
+27,115
New +$4.43M 0.05% 348
2023
Q2
Sell
-7,337
Closed -$1.24M 3015
2023
Q1
$1.24M Buy
7,337
+3,944
+116% +$704K 0.01% 1003
2022
Q4
$574K Sell
3,393
-1,074
-24% -$195K 0.01% 1416
2022
Q3
$836K Sell
4,467
-4,532
-50% -$956K 0.01% 1135
2022
Q2
$1.46M Buy
8,999
+4,695
+109% +$743K 0.02% 965
2022
Q1
$810K Sell
4,304
-19,978
-82% -$3.8M 0.01% 1569
2021
Q4
$6.43M Buy
24,282
+18,271
+304% +$4.92M 0.04% 395
2021
Q3
$1.74M Sell
6,011
-7,237
-55% -$1.86M 0.01% 1407
2021
Q2
$2.65M Buy
13,248
+783
+6% +$152K 0.01% 957
2021
Q1
$2.42M Sell
12,465
-33,322
-73% -$6.83M 0.01% 921
2020
Q4
$8.77M Buy
45,787
+44,852
+4,797% +$8.16M 0.05% 295
2020
Q3
$138K Sell
935
-30,964
-97% -$4.43M ﹤0.01% 2324
2020
Q2
$3.94M Buy
31,899
+7,079
+29% +$833K 0.03% 461
2020
Q1
$2.4M Buy
24,820
+15,493
+166% +$1.5M 0.02% 704
2019
Q4
$863K Sell
9,327
-2,181
-19% -$183K 0.01% 1372
2019
Q3
$883K Buy
11,508
+8,025
+230% +$702K 0.01% 1471
2019
Q2
$299K Sell
3,483
-670
-16% -$45.7K ﹤0.01% 2200
2019
Q1
$245K Sell
4,153
-20,288
-83% -$1.17M ﹤0.01% 2427
2018
Q4
$1.29M Buy
+24,441
New +$1.43M 0.01% 1161
2018
Q3
Sell
-2,875
Closed -$135K 3417
2018
Q2
$135K Buy
+2,875
New +$118K ﹤0.01% 2883
2017
Q4
Sell
-4,705
Closed -$180K 3545
2017
Q3
$180K Buy
+4,705
New +$197K ﹤0.01% 2674
2017
Q2
Sell
-3,267
Closed -$115K 3446
2017
Q1
$115K Sell
3,267
-10,916
-77% -$346K ﹤0.01% 2885
2016
Q4
$437K Buy
14,183
+7,955
+128% +$246K ﹤0.01% 1784
2016
Q3
$188K Buy
+6,228
New +$188K ﹤0.01% 2549
2016
Q2
Sell
-5,057
Closed -$136K 2921
2016
Q1
$136K Buy
+5,057
New +$124K ﹤0.01% 2441
2015
Q4
Sell
-6,150
Closed -$171K 2934
2015
Q3
$171K Buy
6,150
+3,173
+107% +$115K ﹤0.01% 1548
2015
Q2
$123K Buy
+2,977
New +$109K ﹤0.01% 2244
2015
Q1
Sell
-12,906
Closed -$256K 2979
2014
Q4
$256K Buy
12,906
+915
+8% +$20.5K ﹤0.01% 2213
2014
Q3
$239K Buy
+11,991
New +$252K ﹤0.01% 1891

Other funds holding RGEN

SG Americas Securities's RGEN Position: Q1 2026 in Review

SG Americas Securities reduced its Repligen (RGEN) stake by 62% in Q1 2026, selling an estimated $1.29M and leaving 5,644 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

SG Americas Securities first reported a position in RGEN in Q3 2014 and has held it in 39 quarters since. The position peaked at $8.77M in Q4 2020. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • SG Americas Securities held 5,644 shares of Repligen worth $665K as of Q1 2026.
  • SG Americas Securities sold 9,249 Repligen shares in Q1 2026, an estimated $1.29M.
  • Repligen made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2015 holding.
  • SG Americas Securities first reported a position in Repligen in Q3 2014 and has held it in 39 quarters since.
  • SG Americas Securities's Repligen position peaked at $8.77M in Q4 2020.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.